Knowing what’s on the market for AMD and GA aids in preserving vision.
Sheila Setork, OD
Advertisement
Articles by Sheila Setork, OD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Ocugen completes dosing early in phase 2/3 GARDian3 trial for Stargardt disease
2
OLN324 shows comparable vision gains, potential durability advantage vs faricimab in phase 1b wAMD, DME study
3
Tattoo-associated uveitis: An emerging eye health challenge
4
FDA grants RMAT designation to RTx-015 optogenetic gene therapy for retinitis pigmentosa
5